Article ID Journal Published Year Pages File Type
3339682 Allergologia et Immunopathologia 2014 8 Pages PDF
Abstract
Omalizumab promoted a global benefit on QoL and asthma control outcomes. It also yielded a reduction in asthma exacerbations and unscheduled health care visits, a steroid-sparing effect, and an improvement in lung function. The drug was found to be generally safe and well-tolerated.
Keywords
Related Topics
Life Sciences Immunology and Microbiology Immunology
Preview
Short and long-term quality of life and asthma control with omalizumab therapy in a real life setting in Portugal
Authors
, , ,